Vraylar 1.5 MG capsule 30S

Ended Awarded

Contract number
SPE2DB25FBRWG
Awardee
Awarding agency
Obligated
$96,227

Award facts

Contract value 100% obligated
$96,227.07 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency awarded a delivery order valued at $96,227.07 to AmerisourceBergen Drug Corp for the supply of Vraylar 1.5 mg capsules (30-count units) on September 16, 2025, with an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and specifies Conshohocken, Pennsylvania as the place of performance. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider headquartered in Pennsylvania that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to meet diverse pharmaceutical procurement requirements through open competition, with delivery orders consistently utilizing firm fixed pricing structures. Under the DLA Troop Support Medical IDC, AmerisourceBergen supplies specialty medications, brand-name and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, serving customers including the Defense Health Agency and U.S. Coast Guard.

Quick answers

Who was awarded contract SPE2DB25FBRWG?

SPE2DB25FBRWG was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 16, 2025.

How much is contract SPE2DB25FBRWG worth?

The government has obligated $96,227 on SPE2DB25FBRWG.

Is contract SPE2DB25FBRWG an order under another contract?

Yes. SPE2DB25FBRWG is a delivery order under SPE2DB24D2011, an indefinite delivery contract.

Was contract SPE2DB25FBRWG competed?

The extent of competition for SPE2DB25FBRWG was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award